Balasa, Rodica <br/><br/>
Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response.  [electronic resource] 

 -  CNS & neurological disorders drug targets  2017 
 - 93-101 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1996-3181 
<br/><br/><label>Standard No.: </label>10.2174/1871527315666160615110739  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Brain--diagnostic imaging<br/>Cytokines--blood<br/>Disability Evaluation<br/>Female<br/>Humans<br/>Interferon beta-1a--therapeutic use<br/>Interleukin-10--blood<br/>Interleukin-17--blood<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Prospective Studies<br/>Transforming Growth Factor beta1--blood<br/>Treatment Outcome<br/>Young Adult